Evidence for Activity of GBR830 (Anti-Ox40) in Extrinsic and Intrinsic Atopic Dermatitis (AD) in a Phase 2a Study
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.385
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
Elsevier BV